A real-world study of sorafenib and lenvatinib: A retrospective review of multikinase inhibitor therapies for hepatocellular carcinoma in an Australian tertiary treatment center

被引：0
|
作者：
Patwala, K. [1 ]
Alam, W. [1 ]
Ng, S. [1 ]
O'Neill, P. [1 ]
Mishra, G. [1 ]
Bell, S. [1 ]
Dev, A. [1 ,2 ]
机构：
[1] Monash Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
368
引用
收藏
页码：97 / 98
页数：2
相关论文
共 50 条
  • [1] Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
    Kurvi Patwala
    David Stephen Prince
    Yael Celermajer
    Waafiqa Alam
    Eldho Paul
    Simone Irene Strasser
    Geoffrey William McCaughan
    Paul Gow
    Siddharth Sood
    Elise Murphy
    Stuart Roberts
    Elliot Freeman
    Elizabeth Stratton
    Scott Anthony Davison
    Miriam Tania Levy
    McCawley Clark-Dickson
    Vi Nguyen
    Sally Bell
    Amanda Nicoll
    Ashley Bloom
    Alice Unah Lee
    Marno Ryan
    Jessica Howell
    Zina Valaydon
    Alexandra Mack
    Ken Liu
    Anouk Dev
    [J]. Hepatology International, 2022, 16 : 1170 - 1178
  • [2] Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study
    Patwala, Kurvi
    Prince, David Stephen
    Celermajer, Yael
    Alam, Waafiqa
    Paul, Eldho
    Strasser, Simone Irene
    McCaughan, Geoffrey William
    Gow, Paul
    Sood, Siddharth
    Murphy, Elise
    Roberts, Stuart
    Freeman, Elliot
    Stratton, Elizabeth
    Davison, Scott Anthony
    Levy, Miriam Tania
    Clark-Dickson, Mccawley
    Vi Nguyen
    Bell, Sally
    Nicoll, Amanda
    Bloom, Ashley
    Lee, Alice Unah
    Ryan, Marno
    Howell, Jessica
    Valaydon, Zina
    Mack, Alexandra
    Liu, Ken
    Dev, Anouk
    [J]. HEPATOLOGY INTERNATIONAL, 2022, 16 (05) : 1170 - 1178
  • [3] Risk factors for hepatic encephalopathy in hepatocellular carcinoma after sorafenib or lenvatinib treatment: a real-world study
    Chen, Bowen
    Zhang, Linzhi
    Cheng, Jiamin
    Yang, Xu
    Lei, Jin
    Wu, Tong
    Yan, Tao
    Li, Yinyin
    Lu, Yinying
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S388 - S388
  • [4] Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
    Chen, Bowen
    Zhang, Linzhi
    Cheng, Jiamin
    Wu, Tong
    Lei, Jin
    Yang, Xu
    Zhang, Rongling
    Safadi, Rifaat
    Li, Yinyin
    Si, Tongguo
    Lu, Yinying
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 4429 - 4437
  • [5] Real-world evidence of sorafenib for the treatment of hepatocellular carcinoma: A single-center study
    Lopez-Lopez, Aida
    Gayoso-Rey, Monica
    Garcia-Beloso, Nerea
    Romero-Ventosa, Yaiza
    Robles-Torres, David
    Martinez-Reglero, Cristina
    Pineiro-Corrales, Guadalupe
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1345 - 1349
  • [6] Comparative efficacy of systemic sequential regorafenib after sorafenib or lenvatinib treatment failure for advanced hepatocellular carcinoma: A retrospective, multi-center, real-world study
    Song, D.
    Zheng, L.
    Zhang, A.
    Cao, F.
    Hao, W.
    Zhao, Z.
    Zheng, J.
    Lu, D.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S615 - S615
  • [7] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Chen, Jinbin
    Xiong, Peiyao
    Nie, Man
    Pan, Yangxun
    Wang, Juncheng
    Hu, Dandan
    Zhou, Zhongguo
    Zhang, Yaojun
    Chen, Minshan
    Xu, Li
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2491 - 2500
  • [8] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Jinbin Chen
    Peiyao Xiong
    Man Nie
    Yangxun Pan
    Juncheng Wang
    Dandan Hu
    Zhongguo Zhou
    Yaojun Zhang
    Minshan Chen
    Li Xu
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2491 - 2500
  • [9] Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
    Welland, Sabrina
    Leyh, Catherine
    Finkelmeier, Fabian
    Jefremow, Andre
    Shmanko, Kateryna
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Jeliazkova, Petia
    Best, Jan
    Fruendt, Thorben W.
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Greil, Richard
    Fricke, Christina
    Sookthai, Disorn
    Guenther, Rainer
    Schmiderer, Andreas
    Wege, Henning
    Venerito, Marino
    Ehmer, Ursula
    Mueller, Martina
    Strassburg, Christian P.
    Weinmann, Arndt
    Siebler, Jurgen
    Waidmann, Oliver
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    [J]. LIVER CANCER, 2022, 11 (03) : 219 - 232
  • [10] Efficacy and safety comparison between Lenvatinib and Sorafenib in hepatocellular carcinoma treatment: a systematic review and meta-analysis of real-world study
    Hua, Xuefeng
    Yin, Ziwei
    Liang, Jin
    Chen, Wenbin
    Gong, Hui
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (01) : 120 - 128
12345